Xeris Biopharma Holdings, Inc.
Stable formulations for parenteral injection of small molecule drugs

Abstract:

Disclosed is a stable liquid formulation for parenteral injection comprising a biocompatible non-aqueous solvent and a small molecule drug, or a salt thereof, solubilized within the non-aqueous solvent, wherein the liquid formulation comprises less than 10% by weight residual water, and wherein the volume of the liquid formulation to be parenterally injected is from 0.1 .mu.l to 3 ml.